Alexandra Kupke

Veterinary pathologist, interested in neurotropic viral infections, highly pathogenic viruses and development of prophylactic/therapeutic measures

[VIGILANT @VIGILANT_EU]

🚨VIGILANT is developing antivirals that block cellular factors viruses depend on - proteases and Sec61.

This thread 🧵 explains why cellular proteases are attractive targets to stop viruses before they spread. 🦠🔒

[World Organisation for Animal Health @WOAH]

Let's talk about the forgotten victims of Ebola Virus Disease (EVD).

Decades of research have shown that humans are only one part of a much larger ecological story involving wildlife, ecosystems and the complex interfaces where diseases emerge. Research has revealed that the virus is one of the greatest infectious dangers facing Africa’s great apes.

This means that to prevent future outbreaks, surveillance must also extend to wildlife, and go beyond hospitals and clinics. Integrated surveillance benefits both biodiversity conservation and public health by improving preparedness before pathogens cross species barriers

This is precisely the ambition of the ZOOSURSY project which aims to strengthen surveillance systems for zoonotic diseases at the human-animal-environment interface in 17 African countries.

Read the article to take a deeper look: https://t.co/ATLsJFUOFD

[Alexandra Kupke @AlexandraKupke]

Honoured and thankful to the Von Behring-Röntgen-Stiftung for funding our work on CNS pathology and the innate immune response following Nipah virus infection 🧠🦠

https://t.co/UnUmwMVLJ4

[VIGILANT @VIGILANT_EU]

https://t.co/n5Zf5bOAod

This recent Nipah virus outbreak is a stark reminder of how quickly zoonotic viruses can emerge & spread.

The VIGILANT project is tackling this threat head-on by developing medical compounds that target host cell pathways hijacked by Nipah & related viruses.
By focusing on shared mechanisms of viral protein expression and activation, VIGILANT aims to create broad-spectrum antivirals that are ready before the next outbreak hits.

Preparedness saves lives.

[Alexandra Kupke @AlexandraKupke]

Excited to share our latest publication on #ebolavirus and #nipahvirus infection of organotypic brain slices 🥳🦠🧠
#3R

https://t.co/ZdS5lF8rfI

[Alexandra Kupke @AlexandraKupke]

Was haben wir in den letzten Jahrzehnten gelernt? Wir müssen uns besser auf neue Pandemien vorbereiten. An der Uni Marburg @Uni_MR wird gerade ein entscheidender Schritt in die richtige Richtung gemacht.

https://t.co/pfgAy7FRTW

[Alexandra Kupke @AlexandraKupke]

Wichtige Stellungnahme! Gut gemeint ist nämlich nicht unbedingt gut gemacht. Und im Fall von #WissZeitVG leider komplett an den realen Bedürfnissen vorbei.

[GfV - Gesellschaft für Virologie @GesVirologie]

Wir haben mit 15 weiteren wissenschaftlichen Gesellschaften die Stellungnahme der @GBM_eV mitgezeichnet zum #WissZeitVG ⬇️

[Alexandra Kupke @AlexandraKupke]

#GfV2024
Missed the posters of Michelle Gellhorn Serra and Karina Renner at today’s get together? Feel free to approach the Kupke lab at any time!

[GfV - Gesellschaft für Virologie @GesVirologie]

The #VIROCARD grandprix is a #jGfV icebreaker event for young virologists at #GfV2024. Look out for participating PIs and get a card by asking a question. Those 2 who collected the most cards, win 2x 200€ vouchers. Deadline: Thursday 28.3. 9am at the GfV booth.

[GfV - Gesellschaft für Virologie @GesVirologie]

News from the #jGfV:
the young PI working group had its first annual meeting at the @Uni_MR with the former and current president of the GfV.
More upcoming events can be found here👇
https://t.co/V6MgF4BE43

[Alexandra Kupke @AlexandraKupke]

@AnkeWerner @DiamondLightSou @XChem_DLS @SBeckerLab 🦋💎❤️

[Biedenkopf Lab @BiedenkopfL]

We are hiring!
Seeking for enthusiastic and motivated PhD student!
https://t.co/wIUhciEiBA

[GfV - Gesellschaft für Virologie @GesVirologie]

After last year's kick off meeting, the #YoungPI working group invites Junior Group Leaders/Junior Profs. to their 1st Annual Meeting. 11th-12th December in Marburg!
Strong collaborations are key to success & we invited some fantastic guests on this topic.
More info below 👇

[Alexandra Kupke @AlexandraKupke]

@BMauschen @ResearcherLucy Like the formalinophilic fungus during my studies 🥹❤️🍄

[janis müller @janis_mue11er]

Ready for viral extracellular vesicle research?🦟🏐🦠Join my new team and explore tiny particles!🧪 https://t.co/Rm2Ak4Q8BB #ExtracellularVesicles #ZikaVirus #flavivirus @GSEV10 @GesVirologie

[Alexandra Kupke @AlexandraKupke]

Proud to be part of this great collaboration @SBeckerLab and Sutter lab, LMU Munich. https://t.co/fTc3UUcqbU

[DZIF (inaktiv) @DZIF_]

Am @UKEHamburg startet eine klinische Studie zur #Auffrischungsimpfung mit Vektor-Impfstoff. Gesucht werden gesunde Frauen und Männer, 18-64 J., die seit mind. 6 Monaten vollständig mit einem mRNA-Impfstoff gegen #SARSCoV2 geimpft sind. Mehr Info: https://t.co/veyj7koBeJ

[Alexandra Kupke @AlexandraKupke]

Honoured to be part of the project 🤩
Post-viral effects of COVID-19 in the olfactory system and their impli... https://t.co/Tm71Pc3txZ

[DZIF (inaktiv) @DZIF_]

Wir suchen #Probanden für unsere klinische Impfstudie zu #COVID19. Es ist ein akademisches Projekt und keine Studie der Pharmaindustrie.
Du bist noch nicht geimpft und 18-64 J. alt? Informiere und melde dich an unter: https://t.co/dXoThfOebx
Aufwandsentschädigung bis zu 1.475 €.

[DZIF (inaktiv) @DZIF_]

#MERS #Coronavirus: Die Impfstoffentwicklung geht in die nächste Runde: https://t.co/hUDRQEyTEL

@UKEHamburg @idtbiologika @marylyn_addo @SBeckerLab
#Impfstoff #Impfstoffentwicklung